Results 261 to 270 of about 2,139,028 (342)

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin, Hui‐An Lin, Sheng‐Feng Lin   +2 more
wiley   +1 more source

High-Spin Porphyrin Polyradicals. [PDF]

ACS Omega
Betkhoshvili S, Poater J, Moreira IPR, Bofill JM.   +3 more
europepmc   +1 more source

Polar reciprocals with respect to a pair of triangles

, 1922
Nina Mildred McLatchey
openalex   +1 more source

The Case of a 28‐Year‐Old Woman With Medically Refractory Focal Epilepsy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT We present the case of a 28‐year‐old right‐handed woman with medically refractory focal epilepsy. Her seizure semiology and electroencephalography (EEG) indicated a seizure onset zone in the right central‐parietal area. However, both MRI and PET scans were unremarkable, showing no focal lesions or areas of altered metabolism.
Rishi Sharma, Ilo Leppik, Thomas Henry, Thaddeus Walczak, Sima Patel, Robert McGovern   +5 more
wiley   +1 more source

A droplet microfluidics-based platform for generating target-specific, natively-paired immune libraries and identifying potent and developable antibodies. [PDF]

Sci Rep
Ramasubramanian A, Deveney BT, Clark SA, Boutin P, Keepseagle K, Riahi S, Lao T, Salemi M, Kathuria S, Amengual-Rigo P, Dimova D, Marcovici L, Hopke J, Newton J, Mix K, Kramer K, Erasimus H, Furtmann N, Mottet G, Suslov N, Mahendra A, Pemmaraju SR, Chowdhury PS, Weitz DA, Heyman JA.   +24 more
europepmc   +1 more source

Pair-distribution function analysis of the structural valence transition in Cp{sub 2}{sup *}Yb(4,4'-Me{sub 2}-bipy)

, 2010
Corwin H. Booth, E. D. Bauer, Emil S. Božin, Simon J. L. Billinge, Marc D. Walter   +4 more
openalex   +1 more source

Metal‐Free Electron Donor‐Acceptor Pair Enabled Long‐Term Stability of Li‐CO₂ Battery [PDF]

Zhihao Liu, Xingwu Zhai, Tianchen Wei, Yuchun Liu, Zhixin Sun, Jing Zhang, Honghe Ding, Yujian Xia, Min Zhou   +8 more
openalex   +1 more source

Exploratory Analysis of ELP1 Expression in Whole Blood From Patients With Familial Dysautonomia

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Familial dysautonomia (FD) is a hereditary neurodevelopmental disorder caused by aberrant splicing of the ELP1 gene, leading to a tissue‐specific reduction in ELP1 protein expression. Preclinical models indicate that increasing ELP1 levels can mitigate disease manifestations.
Alejandra González‐Duarte, Lucy Norcliffe‐Kaufmann, Maria Luisa Cotrina, Zenith Khan, Kaia Dalamo, Patricio Millar Vernetti, Matthew Lawless, Elisabetta Morini, Monica Salani, Marla Weetall, Jana Narasimhan, Agostino G. Rocha, Susan A. Slaugenhaupt, Horacio Kaufmann   +13 more
wiley   +1 more source

A unifying model for microRNA-guided silencing of messenger RNAs. [PDF]

Nat Commun
Chatterjee T, Mandal S, Ray S, Johnson-Buck A, Walter NG.   +4 more
europepmc   +1 more source

Olink Proteomics Analysis Reveals Heterogeneous Responses to FcRn Blockade in Anti‐AChR Antibody‐Positive Myasthenia Gravis: FGF‐19 as a Novel Biomarker

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to systematically observe the clinical manifestations, immune cell subsets, and dynamic changes in serological indicators in patients with myasthenia gravis (MG) before and after efgartigimod (EFG) treatment. Methods We analyzed the baseline data, laboratory parameters, and lymphocyte subset proportions in MG ...
Tiancheng Luo, Deyou Peng, Zhouao Zhang, Mingjin Yang, Xinyan Guo, Tianyu Ma, Xiaoyu Huang, Mingming Xu, Linlin Fu, Yong Zhang   +9 more
wiley   +1 more source